176 related articles for article (PubMed ID: 17326321)
1. t(8;16) AML developed subsequent to breast cancer therapy.
Sahin FI; Yilmaz Z; Karakuş S; Boğa S; Akçali Z; DemIrhan B
Hematology; 2006 Jun; 11(3):153-5. PubMed ID: 17326321
[TBL] [Abstract][Full Text] [Related]
2. Gallbladder metastases of breast cancer: from clinical-pathological patterns to diagnostic and therapeutic strategy.
Di Vita M; Zanghì A; Lanzafame S; Cavallaro A; Piccolo G; Berretta M; Grosso G; Cappellani A
Clin Ter; 2011; 162(5):451-6. PubMed ID: 22041804
[TBL] [Abstract][Full Text] [Related]
3. Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm.
Calais G; Berger C; Descamps P; Chapet S; Reynaud-Bougnoux A; Body G; Bougnoux P; Lansac J; Le Floch O
Cancer; 1994 Aug; 74(4):1283-8. PubMed ID: 8055449
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy and concomitant irradiation in inflammatory breast cancer.
Tubiana-Mathieu N; Lejeune C; Bonnier P; Genet D; Adjadj DJ; Berda JF; Muracciole X; Delaby F; Clavere P; Benyoub A; Rhein B; Juin B; Piana L
Anticancer Res; 2001; 21(4B):3061-7. PubMed ID: 11712811
[TBL] [Abstract][Full Text] [Related]
5. Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer.
Di Lauro L; Vici P; Del Medico P; Laudadio L; Tomao S; Giannarelli D; Pizzuti L; Sergi D; Barba M; Maugeri-Saccà M
Breast Cancer Res Treat; 2013 Aug; 141(1):119-23. PubMed ID: 23982884
[TBL] [Abstract][Full Text] [Related]
6. Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
Kröger N; Damon L; Zander AR; Wandt H; Derigs G; Ferrante P; Demirer T; Rosti G; ; ;
Bone Marrow Transplant; 2003 Dec; 32(12):1153-7. PubMed ID: 14647269
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of immediate breast reconstruction and radiotherapy: factors associated with complications].
Gross E; Hannoun-Levi JM; Rouanet P; Houvenaeghel G; Teissier E; Ellis S; Resbeut M; Tallet A; Vaini Cowen V; Azria D; Cowen D
Cancer Radiother; 2010 Dec; 14(8):704-10. PubMed ID: 20674442
[TBL] [Abstract][Full Text] [Related]
8. Infiltrating ductal carcinoma and synchronous malignant phyllodes tumour. Diagnostic and therapeutic approaches.
Merck B; Cansado Martínez P; Pérez Ramos M; Martínez Banaclocha N; Lacueva Gómez FJ; Calpena R
Clin Transl Oncol; 2006 Nov; 8(11):830-2. PubMed ID: 17134973
[TBL] [Abstract][Full Text] [Related]
9. Therapy-related myeloid neoplasm with bone marrow involvement, myelosarcoma, and a t(8;16)(p11.2;p13.3)-a case report.
Chakraborty S; Adams J; Nassiri M; Vance GH
Cancer Genet; 2014; 207(10-12):511-5. PubMed ID: 25487769
[TBL] [Abstract][Full Text] [Related]
10. [Synchronous bilateral breast cancer in a male].
García-Mejido JA; Delgado-Jiménez C; Gutiérrez-Palomino L; Sánchez-Sevilla M; Iglesias-Bravo E; Caballero-Fernández V
Cir Cir; 2013; 81(3):225-7. PubMed ID: 23769252
[TBL] [Abstract][Full Text] [Related]
11. [Response evaluation with mammography and ultrasound].
Junkermann H; Schmid H; Sinn HP; Wallwiener D
Zentralbl Gynakol; 1996; 118(10):572-3. PubMed ID: 8999712
[No Abstract] [Full Text] [Related]
12. Chronic myeloid leukemia following cyclophosphamide-containing chemotherapy in a breast cancer patient.
Porta C; Casagranda I; Semino G; Moroni M; Ratto C
Haematologica; 1993; 78(1):56-7. PubMed ID: 8387943
[No Abstract] [Full Text] [Related]
13. A remarkable case of cutaneous metastatic breast carcinoma.
Santiago F; Saleiro S; Brites MM; Frutuoso C; Figueiredo A
Dermatol Online J; 2009 Jul; 15(7):10. PubMed ID: 19903438
[TBL] [Abstract][Full Text] [Related]
14. Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer.
Han W; Han MR; Kang JJ; Bae JY; Lee JH; Bae YJ; Lee JE; Shin HJ; Hwang KT; Hwang SE; Kim SW; Noh DY
BMC Cancer; 2006 Apr; 6():92. PubMed ID: 16608533
[TBL] [Abstract][Full Text] [Related]
15. Therapy-related acute myelomonocytic leukemia following successful treatment for acute promyelocytic leukemia.
Todisco E; Testi AM; Avvisati G; Moleti ML; Cedrone M; Cimino G; Mancini F; Amadori S; Mandelli F
Leukemia; 1995 Sep; 9(9):1583-5. PubMed ID: 7658728
[TBL] [Abstract][Full Text] [Related]
16. Therapy-related acute myeloid leukemia with inv(16) after successful therapy for de novo acute myeloid leukemia with t(8;21).
Shao H; Yang Q; Wu C; Cen J; Chen S; Pan J
Ann Hematol; 2017 Dec; 96(12):2127-2129. PubMed ID: 28840298
[No Abstract] [Full Text] [Related]
17. Treatment of advanced breast cancer: How much chemotherapy is enough?
DiPaola RS; Kaufman A; Mikhail MM
Semin Oncol; 1996 Jun; 23(3):xv-xxii; discussion xxii-xxiv. PubMed ID: 8658211
[No Abstract] [Full Text] [Related]
18. Thyroid cancer presenting as a PET incidentaloma in a patient with concomitant breast cancer metastases to the thyroid.
Leboeuf R; Bénard F; Langlois MF
Clin Nucl Med; 2006 Jul; 31(7):382-5. PubMed ID: 16785803
[TBL] [Abstract][Full Text] [Related]
19. Biphenotypic acute leukemia following intensive adjuvant chemotherapy for breast cancer: case report and review of the literature.
Briasoulis E; Tzouvara E; Tsiara S; Vartholomatos G; Tsekeris P; Bourantas K
Breast J; 2003; 9(3):241-5. PubMed ID: 12752636
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy in locally advanced breast cancer.
Singh G; Singh DP; Gupta D; Muralikrishna BV
J Surg Oncol; 1996 Jan; 61(1):38-41. PubMed ID: 8544458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]